ASEP Medical Holdings Inc. (CSE:ASEP)

Market Cap	3.56M -77.2%
Revenue (ttm)	296.77K +21.7%
Net Income	-7.84M
EPS	-0.83
Shares Out	11.12M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,275
Average Volume	13,830
Open	0.3200
Previous Close	0.3000
Day's Range	0.3200 - 0.3200
52-Week Range	0.0900 - 0.9000
Beta	-1.55
RSI	54.85
Earnings Date	May 1, 2026

About ASEP Medical Holdings

ASEP Medical Holdings Inc., together with its subsidiaries, engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics. It offers peptide technologies that cover therapeutic applications, including bacterial biofilm infections, anti-inflammatory, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and medical devices with anti-microbial and antifouling coating. The company was fo...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2021
• Employees: 6
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: ASEP

Financial Performance

In 2024, ASEP Medical Holdings's revenue was 297,586, an increase of 1307.69% compared to the previous year's 21,140. Losses were -8.27 million, 0.55% more than in 2023.